ANDREW PHILLIPS plan to sell securities of ENLIVEN THERAPEUTICS, INC. under Form 144

ANDREW PHILLIPS filed Form 144 to notify SEC of plan to sell 26035 units of ENLIVEN THERAPEUTICS, INC. securities around 2026-03-31, with aggregate market value of $1,003,610.20. The total outstanding units is 59800406.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in past 3 months include: On 02/02/2026, sold 21844 units for $611719.38; On 01/22/2026, sold 1520 units for $42564.10;